|
nasopharyngeal carcinoma |
14 |
|
cancer susceptibility genes |
13 |
|
early-age onset |
13 |
|
mst1r |
13 |
|
whole-exome sequencing |
13 |
|
esophageal squamous cell carcinoma (escc) |
11 |
|
metastasis |
11 |
|
nasopharyngeal carcinoma (npc) |
11 |
|
nidogen-2 (nid2) |
11 |
|
promoter hypermethylation |
11 |
|
dna methylation |
10 |
|
leucocyte telomere length |
9 |
|
npc risk |
9 |
|
prognostic marker |
9 |
|
survival |
9 |
|
telomere biology |
9 |
|
circulating neoplastic cell |
8 |
|
circulating tumor dna |
8 |
|
liquid biopsy |
8 |
|
biomarker |
6 |
|
dna damage repair pathway |
6 |
|
early diagnosis |
6 |
|
epstein−barr virus |
6 |
|
histone bivalent switch |
6 |
|
mlh1 |
6 |
|
ms‐hrm |
6 |
|
npc |
6 |
|
apoptosis |
4 |
|
differentially expressed in squamous cell carcinoma 1 |
4 |
|
esophageal squamous cell carcinoma |
4 |
|
transmembrane serine protease |
4 |
|
biomarkers |
3 |
|
breast cancer |
3 |
|
cancer prognosis |
3 |
|
cell signaling pathways |
3 |
|
deep learning |
3 |
|
dna repair gene |
3 |
|
genetic predisposition |
3 |
|
germline polymorphisms |
3 |
|
gwas |
3 |
|
hla |
3 |
|
low-dose volume |
3 |
|
lymphopenia |
3 |
|
methylation |
3 |
|
radiotherapy (rt) |
3 |
|
rpa1 |
3 |
|
telomere |
3 |
